Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 16:9:44.
doi: 10.1186/1743-422X-9-44.

Attenuation of influenza virus infectivity with herbal-marine compound (HESA-A): an in vitro study in MDCK cells

Parvaneh Mehrbod  1 , Aini Ideris, Abdul Rahman Omar, Mohd Hair-Bejo, Sheau Wei Tan, Masoumeh Tavassoti Kheiri, Mansoureh Tabatabaian
Affiliations

Attenuation of influenza virus infectivity with herbal-marine compound (HESA-A): an in vitro study in MDCK cells

Parvaneh Mehrbod et al. Virol J. .

Abstract

Background: The influenza virus is still one of the most important respiratory risks affecting humans which require effective treatments. In this case, traditional medications are of interest. HESA-A is an active natural biological compound from herbal-marine origin. Previous studies have reported that the therapeutic properties of HESA-A are able to treat psoriasis vulgaris and cancers. However, no antiviral properties have been reported.

Methods: This study was designed to investigate the potential antiviral properties of HESA-A and its effects in modulating TNF-α and IL-6 cytokine levels. HESA-A was prepared in normal saline as a stock solution (0.8 mg/ml, pH = 7.4). Percentages of cell survival when exposed to different concentrations of HESA-A at different time intervals was determined by MTT assay. To study the potential antiviral activity of HESA-A, Madin-Darby Canine Kidney (MDCK) cells were treated with the effective concentration (EC50) of HESA-A (0.025 mg/ml) and 100 TCID50/0.1 ml of virus sample under different types of exposure.

Results: Based on the MTT method and hemagglutination assay (HA), HESA-A is capable of improving cell viability to 31% and decreasing HA titre to almost 99% in co-penetration exposures. In addition, based on quantitative real-time PCR (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA), it was found that HESA-A causes decrements in TNF-α and IL-6 cytokine expressions, which was significant for TNF-α (p ≤ 0.05) but not for IL-6.

Conclusion: In conclusion, HESA-A was effective against influenza infection through suppressing cytokine expression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MTT optical densities for cell viability in response to different types of exposure of HESA-A and virus (averages of 4 independent tests) (mean ± SD). *: Significantly different from values obtained for the co-penetration treatment compared to the virus untreated sample (p < 0.05).
Figure 2
Figure 2
Comparison of the percent of protection of HESA-A and Amantadine on cell viability. Data analyzed by SPSS, one way ANOVA are averages of 4 independent experiments (mean ± SD). HESA-A showed a higher degree of protection towards cell viability in comparison with Amantadine treatments. It was significantly higher in co- and pre-penetration treatments. *: Significantly different from values obtained for co- & pre-penetration treatments compared to Amantadine treatments (p < 0.05).
See this image and copyright information in PMC

References

    1. Wagman P, Leong M, Simmen K. Development of a novel influenza A antiviral assay. J Virol Methods. 2002;105:105–114. doi: 10.1016/S0166-0934(02)00088-5. - DOI - PubMed
    1. Pathumwadee I, Chittima L, Thanyada R, Arthorn L, Maturos M, Panita D, Ornjira A, Krit C, Nopphorn K, Pornthep S. et al.How amantadine and rimantadine inhibit proton transport in the M2 protein channel. J Mol Graph Model. 2008;27:342–348. doi: 10.1016/j.jmgm.2008.06.002. - DOI - PubMed
    1. Moallem S, Ahmadi A, Moshafi M, Taghavi M. Evaluation of fetal toxicity of HESA-A, a natural anticancer agent, in mice. J Kerman Univ Med Sci. 2007;14:124–133.
    1. Ahmadi A, Barikbin B, Naseri M, Mohagheghi M. The effect of HESA-A on psoriasis vulgaris. J Drugs Dermatol. 2008;7:559–561. - PubMed
    1. Ahmadi A, Mohagheghi M, Fazeli M, Nahavandian B, Bashardoost N, Musavi-Jarahi A, Gharipoor M. HESA-A, a new treatment for breast cancer and choroidal metastasis. Med Sci Monit. 2005;11:300–303. - PubMed

Publication types

MeSH terms

LinkOut - more resources